We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCLR
2901
DELISTED
Oclaro Inc.
OCLR
| $143K | ﹤0.01% |
62,333
-7,613
| -11% | -$18.6K |
|
|
NUTR
2902
DELISTED
Nutraceutical International Co
NUTR
| $143K | ﹤0.01% |
6,073
-440
| -7% | -$10.5K |
|
2903
Covenant Logistics
CVLG
$1.13B
| $142K | ﹤0.01% |
15,814
-98
| -0.6% | -$1.15K |
|
2904
Miller Industries
MLR
$588M
| $142K | ﹤0.01% |
7,255
-407
| -5% | -$8.05K |
|
|
PWOD
2905
DELISTED
Penns Woods Bancorp
PWOD
| $142K | ﹤0.01% |
5,199
-29
| -0.6% | -$821 |
|
|
SEAC
2906
DELISTED
Seachange International Inc
SEAC
| $142K | ﹤0.01% |
1,131
+48
| +4% | +$6.27K |
|
|
GEN
2907
DELISTED
Genesis Healthcare, Inc.
GEN
| $142K | ﹤0.01% |
23,207
+705
| +3% | +$4.78K |
|
|
FMI
2908
DELISTED
Foundation Medicine, Inc.
FMI
| $142K | ﹤0.01% |
7,686
-1,006
| -12% | -$25.1K |
|
|
DRRX
2909
DELISTED
DURECT Corp
DRRX
| $141K | ﹤0.01% |
7,247
-1,051
| -13% | -$23.9K |
|
2910
Franklin Covey
FC
$247M
| $141K | ﹤0.01% |
8,781
+51
| +0.6% | +$880 |
|
|
BBOX
2911
DELISTED
Black Box Corp
BBOX
| $141K | ﹤0.01% |
9,588
-13,728
| -59% | -$225K |
|
2912
Frontline
FRO
$8.74B
| $140K | ﹤0.01% |
10,385
-523
| -5% | -$7.02K |
|
|
SQNM
2913
DELISTED
SEQUENOM INC NEW
SQNM
| $140K | ﹤0.01% |
79,823
-1,398
| -2% | -$3.42K |
|
|
YDLE
2914
DELISTED
YODLEE INC COMMON STOCK
YDLE
| $140K | ﹤0.01% |
8,694
-342
| -4% | -$5.13K |
|
2915
Ceco Environmental
CECO
$3.95B
| $139K | ﹤0.01% |
16,985
+3,146
| +23% | +$29.5K |
|
2916
Hovnanian Enterprises
HOV
$809M
| $139K | ﹤0.01% |
3,133
-184
| -6% | -$9.04K |
|
|
NNA
2917
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $139K | ﹤0.01% |
2,634
-194
| -7% | -$11.1K |
|
2918
Sierra Bancorp
BSRR
$544M
| $138K | ﹤0.01% |
8,670
-2,087
| -19% | -$35.1K |
|
2919
CRA International
CRAI
$1.17B
| $138K | ﹤0.01% |
6,385
-386
| -6% | -$9.1K |
|
|
CUTR
2920
DELISTED
Cutera, Inc.
CUTR
| $138K | ﹤0.01% |
10,582
-110
| -1% | -$1.63K |
|
2921
Monarch Casino & Resort
MCRI
$2.21B
| $137K | ﹤0.01% |
7,642
-374
| -5% | -$7.04K |
|
|
KEYW
2922
DELISTED
The KEYW Holding Corporation
KEYW
| $137K | ﹤0.01% |
22,291
-87,695
| -80% | -$710K |
|
|
REIS
2923
DELISTED
Reis, Inc.
REIS
| $137K | ﹤0.01% |
6,035
-404
| -6% | -$9.74K |
|
|
BELFB
2924
Bel Fuse Inc Class B
BELFB
$3.61B
| $136K | ﹤0.01% |
6,998
-516
| -7% | -$10.3K |
|
2925
CALL
VanEck Gold Miners ETF
GDX
$22.5B
| $136K | ﹤0.01% |
+9,900
| New | +$143K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.